|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Nasal Polyps | |||||
| 2 | More general conditions related to this trial | ||||
| Nose Diseases | |||||
| Otorhinolaryngologic Diseases | |||||
| Pathological Conditions, Anatomical | |||||
| Polyps | |||||
| 3 | Interventions listed in this trial | ||||
| Mint tea high in rosmarinic acid | |||||
| Mint tea low in rosmarinic acid | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Rosmarinic acid | |||||
| 5 | More general drug interventions related to this trial | ||||
| Analgesics | |||||
| Analgesics, Non-Narcotic | |||||
| Anti-Inflammatory Agents | |||||
| Anti-Inflammatory Agents, Non-Steroidal | |||||
| Antioxidants | |||||
| Antirheumatic Agents | |||||
| Central Nervous System Agents | |||||
| Enzyme Inhibitors | |||||
| Hematologic Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Platelet Aggregation Inhibitors | |||||
| Protease Inhibitors | |||||
| Protective Agents | |||||
| Sensory System Agents | |||||
| Serine Proteinase Inhibitors | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| Hamilton Health Sciences | |||||